Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 1 - 10 of 383 for wuxi. (0.33 seconds)

WuXi Pharmatech released its second...
Rumors Resurface at Bio-Forum 2007 Outsourcing...
Company Will Raise $200 Million -- WuXi...
Company Seeks $715 Million Valuation -- As we reported...
Second Quarter Revenue Lower Than First Quarter...
Stock Opens 30% Higher WuXi...
Second Quarter Reports Are Solid Last week saw the very...
WuXi PharmaTech, the very successful...
WuXi PharmaTech, the Shanghai CRO that...
WuXi PharmaTech will pay $151 million to...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital